Literature DB >> 32109911

The Prevalence and Correlates of Prehospital Delay and Health Belief in Chinese Patients With Colorectal Cancer.

Xiao-Dan Wu1,2,3,4, Ying-Yu Zeng1,2,3,4, Xiao-Jun Wu1,2,3,4, Hui-Ying Qin1,2,3,4.   

Abstract

The objective of this study was to describe prehospital delay and health beliefs in Chinese patients with colorectal cancer. A total of 756 adult Chinese patients with a first-time diagnosis of colorectal cancer were recruited during 2016 in Guangzhou, China. All patients completed the Chinese-language version of a questionnaire developed specifically for this study as well as the Chinese-language version of the Champion Health Belief Model Scale. The results of this study showed that the median length of the prehospital delay was 12 weeks and that the average delay was 18.29 (SD = 14.66) weeks. The rate of prehospital delay was 47.35%. The score of health beliefs among these patients was 115.56 (SD = 9.00) and the average score of the entries was 3.21 (SD = 0.25). Health beliefs about colorectal cancer were negatively correlated with prehospital delay. A multiple logistic regression showed that the level of health beliefs, frequency of physical examinations, occupation, and the site of the cancer were the major factors influencing prehospital delay (p < .05). The patients had a low rate of physical examination (41.40%), and colorectal cancer screening was not routine prior to their physical examination. This study showed that the incidence of prehospital delay among Chinese patients with colorectal cancer was 47.35%. Multiple factors influenced prehospital delay among Chinese patients with colorectal cancer.

Entities:  

Year:  2020        PMID: 32109911     DOI: 10.1097/SGA.0000000000000407

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  4 in total

1.  Identification and verification of the role of crucial genes through which methionine restriction inhibits the progression of colon cancer cells.

Authors:  Liqiang Zhou; Zhiqing Chen; Chuan Liu
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

2.  β-asarone suppresses HCT116 colon cancer cell proliferation and liver metastasis in part by activating the innate immune system.

Authors:  Min Chen; Yu-Wen Zhuang; Cun-En Wu; Hai-Yan Peng; Jun Qian; Jin-Yong Zhou
Journal:  Oncol Lett       Date:  2021-03-31       Impact factor: 2.967

3.  Knowledge and awareness of colorectal cancer risk factors, screening, and associated factors in advanced colorectal cancer patients: a multicenter cross-sectional study in China.

Authors:  Hui-Fang Xu; Xiao-Fen Gu; Xiao-Hui Wang; Wen-Jun Wang; Ling-Bin Du; Shuang-Xia Duan; Yin Liu; Xi Zhang; Yu-Qian Zhao; Li Ma; Yun-Yong Liu; Juan-Xiu Huang; Ji Cao; Yan-Ping Fan; Li Li; Chang-Yan Feng; Xue-Mei Lian; Jing-Chang Du; Jian-Gong Zhang; Yan-Qin Yu; You-Lin Qiao
Journal:  Ann Transl Med       Date:  2022-03

4.  Cancer Burden in China during 1990-2019: Analysis of the Global Burden of Disease.

Authors:  Shu-Zhen Zhang; Li Zhang; Long Xie
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.